Cited by 193Mesenchymal stem cell researchNeonatal Respiratory Health ResearchTransplantation: Methods and Outcomes

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives

Open access

Harrell, C. Randall, Sadikot, Ruxana, Pascual, Jose, Fellabaum, Crissy, Jankovic, Marina Gazdic, Jovicic, Nemanja, Djonov, Valentin, Arsenijevic, Nebojsa, Volarevic, Vladislav·2019·Stem Cells International

DOI 10.1155/2019/4236973PMC PMC6525794

Open this paper in CoChat — free account Open PDF

Abstract

During acute or chronic lung injury, inappropriate immune response and/or aberrant repair process causes irreversible damage in lung tissue and most usually results in the development of fibrosis followed by decline in lung function. Inhaled corticosteroids and other anti-inflammatory drugs are very effective in patients with inflammatory lung disorders, but their long-term use is associated with severe side effects. Accordingly, new therapeutic agents that will attenuate ongoing inflammation and, at the same time, promote regeneration of injured alveolar epithelial cells are urgently needed. Mesenchymal stem cells (MSCs) are able to modulate proliferation, activation, and effector function of all immune cells that play an important role in the pathogenesis of acute and chronic inflammatory lung diseases. In addition to the suppression of lung-infiltrated immune cells, MSCs have potential to differentiate into alveolar epithelial cells in vitro and, accordingly, represent new players in cell-based therapy of inflammatory lung disorders. In this review article, we described molecular mechanisms involved in MSC-based therapy of acute and chronic pulmonary diseases and emphasized current knowledge and future perspectives related to the therapeutic application of MSCs in patients suffering from acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary diseases, and idiopathic pulmonary fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1155/2019/4236973

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED: Ischemia postconditioning and mesenchymal stem cells engraftment synergistically attenuate ischemia reperfusion-induced lung injury in rats
Chen, S., Chen, L., Wu, X., Lin, J., Fang, J., Chen, X., Wei, S., Xu, J., Gao, Q. F., & Kang, M. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.01.039 · Cited by 42
Retracted
Placenta-derived mesenchymal stem cells improve airway hyperresponsiveness and inflammation in asthmatic rats by modulating the Th17/Treg balance
Li, Y., Li, H., Cao, Y., Wu, F., Ma, W., Wang, Y., & Sun, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7605 · Cited by 35
Retracted
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730
Acute Respiratory Distress Syndrome
Ards Definition Task Force (2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 9,066
Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient Mice
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R. W., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,521
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,807
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706

Flagged first, then by citations

Show all 126 references

Research works printed but not linked: 3

2009, Journal of Inflammation Research, 2, 1
2013, Iranian Journal of Allergy, Asthma, and Immunology, 12, 228
2015, International Journal of Clinical and Experimental Pathology, 8, 8958

Sorted by citations

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Lanzoni, G., Linetsky, E., Correa, D., Messinger, S., Marttos, A. C., Jr., Alvarez, R. A., Marttos, A. C., Jr., Gil, A. A., Poggioli, R., Ruiz, P., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0472 · Cited by 419
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Shu, L., Niu, C., Li, R., Huang, T., Wang, Y., Huang, M., Ji, N., Zheng, Y. Y., Chen, X., Shi, L., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01875-5 · Cited by 298
Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice
Dong, L., Wang, Y., Zheng, T., Pu, Y., Ma, Y., Qi, X., Zhang, W., Xue, F., Shan, Z., Liu, J., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02072-0 · Cited by 248
Exosome-functionalized magnesium-organic framework-based scaffolds with osteogenic, angiogenic and anti-inflammatory properties for accelerated bone regeneration.
Kang, Y., Xu, C., Meng, L., Dong, X., Qi, M., & Jiang, D. (2022) · Bioactive materials · doi:10.1016/j.bioactmat.2022.02.012 · Cited by 253
The role of extracellular vesicles in COVID-19 virus infection
Hassanpour, M., Rezaie, J., Nouri, M., & Panahi, Y. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104422 · Cited by 235
Mitochondria and Critical Illness
Supinski, G. S., Schroder, E. A., & Callahan, L. A. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.2182 · Cited by 212
MSC Based Therapies—New Perspectives for the Injured Lung
Behnke, J., Kremer, S., Shahzad, T., Chao, C., Böttcher‐Friebertshäuser, E., Morty, R. E., Bellusci, S., & Ehrhardt, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030682 · Cited by 177
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
Zhang, Y., Ding, J., Ren, S., Wang, W., Yang, Y., Li, S., Meng, M., Wu, T., Liu, D., Tian, S., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01725-4 · Cited by 175
Ischemia–Reperfusion Injury in Lung Transplantation
Chen-Yoshikawa, T. F. (2021) · Cells · doi:10.3390/cells10061333 · Cited by 145
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
Xu, X., Jiang, W., Chen, L., Xu, Z., Zhang, Q., Zhu, M., Ye, P., Li, H., Yu, L., Zhou, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.297 · Cited by 122
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
Rogers, C. J., Harman, R. J., Bunnell, B. A., Schreiber, M. A., Xiang, C. C., Wang, F., Santidrián, A. F., & Minev, B. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02380-2 · Cited by 116
The role of Interleukin 1 receptor antagonist in mesenchymal stem cell‐based tissue repair and regeneration
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, N., Djonov, V., & Volarevic, V. (2020) · BioFactors · doi:10.1002/biof.1587 · Cited by 106
Self-citation
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
Akbari, A., & Rezaie, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01866-6 · Cited by 92
Mesenchymal stromal cells; a new horizon in regenerative medicine
Tavakoli, S., Jafarbeigloo, H. R. G., Shariati, A., Jahangiryan, A., Jadidi, F., Kouhbanani, M. A. J., Hassanzadeh, A., Zamani, M., Javidi-Aghdam, K., & Naimi, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29803 · Cited by 87
Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity
Piekarska, K., Urban‐Wójciuk, Z., Kurkowiak, M., Pelikant‐Małecka, I., Schumacher, A., Sakowska, J., Spodnik, J. H., Arcimowicz, Ł., Zielińska, H., Tymoniuk, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28338-0 · Cited by 86
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Al‐Khawaga, S., & Abdelalim, E. M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01963-6 · Cited by 84
Mesenchymal stem cells as a potential therapy for COVID-19
Liu, S., Peng, D.-Y., Qiu, H., Yang, K., Fu, Z., & Zou, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01678-8 · Cited by 78
Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial
Saleh, M., Vaezi, A. A., Aliannejad, R., Sohrabpour, A. A., Kiaei, S. Z. F., Shadnoush, M., Siavashi, V., Aghaghazvini, L., Khoundabi, B., Abdoli, S., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02483-7 · Cited by 78
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Kavianpour, M., Saleh, M., & Verdi, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01849-7 · Cited by 78
Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes
Taghavi-Farahabadi, M., Mahmoudi, M., Soudi, S., & Hashemi, S. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109865 · Cited by 62
Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review
Talaie, T., DiChiacchio, L., Prasad, N. K., Pasrija, C., Julliard, W. A., Kaczorowski, D. J., Zhao, Y., & Lau, C. L. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001104 · Cited by 68
Stem cell therapy for COVID‐19: Possibilities and challenges
Choudhery, M. S., & Harris, D. T. (2020) · Cell Biology International · doi:10.1002/cbin.11440 · Cited by 57
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
Sadeghi, S., Soudi, S., Shafiee, A., & Hashemi, S. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118493 · Cited by 57
Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis
Kim, G. B., Shon, O., Seo, M., Young Il, C. H. O. I., Park, W.-T., & Lee, G. W. (2021) · Biology · doi:10.3390/biology10040285 · Cited by 57
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives
Guo, H., Su, Y., & Deng, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10085-8 · Cited by 51
Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis
Sveiven, S., & Nordgren, T. M. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00049.2020 · Cited by 53
Personalized pharmacological therapy for ARDS: a light at the end of the tunnel
Silva, P. L., Pelosi, P. P., & Rocco, P. R. M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1699531 · Cited by 50
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment
Aghayan, H. R., Salimian, F., Abedini, A., Ghazi, S. F., Yunesian, M., Alavi-Moghadam, S., Makarem, J., Majidzadeh‐A, K., Hatamkhani, A., Moghri, M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02953-6 · Cited by 49
Senescence in Pulmonary Fibrosis: Between Aging and Exposure
Venosa, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606462 · Cited by 51
Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases
Hwang, H. S., Kim, H., Han, G., Lee, J. W., Kim, K., Kwon, I. C., Yang, Y., & Kim, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115487 · Cited by 48
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Sharma, D., & Zhao, F. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00147-x · Cited by 44
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Chen, L., Qu, J., Kalyani, F. S., Zhang, Q., Fan, L., Fang, Y., Li, Y., & Xiang, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04096-y · Cited by 47
Mesenchymal stem cells in radiation-induced lung injury: From mechanisms to therapeutic potential
Hou, G., Li, J., Liu, W., Wei, J., Xin, Y., & Jiang, X. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1100305 · Cited by 43
Molecular techniques for respiratory diseases: MicroRNA and extracellular vesicles
Gon, Y., Shimizu, T., Mizumura, K., Maruoka, S., & Hikichi, M. (2019) · Respirology · doi:10.1111/resp.13756 · Cited by 42
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
Fröhlich, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020232 · Cited by 40
Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis
Li, X., Cai, H., Cai, Y., Zhang, Q., Ding, Y., & Zhuang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629854 · Cited by 37
Unraveling the therapeutic effects of mesenchymal stem cells in asthma
Mirershadi, F., Ahmadi, M., Rezabakhsh, A., Rajabi, H., Rahbarghazi‬, R., & Keyhanmanesh, ‬. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01921-2 · Cited by 37
Cell-Enriched Lipotransfer (CELT) Improves Tissue Regeneration and Rejuvenation without Substantial Manipulation of the Adipose Tissue Graft
Prantl, L., Eigenberger, A., Reinhard, R., Siegmund, A., Heumann, K., & Felthaus, O. (2022) · Cells · doi:10.3390/cells11193159 · Cited by 38
A Small-Sized Population of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Shows High Stemness Properties and Therapeutic Benefit
Kim, M., Bae, Y. K., Um, S., Kwon, J. H., Kim, G.-H., Choi, S. J., Oh, W., & Jin, H. J. (2020) · Stem Cells International · doi:10.1155/2020/5924983 · Cited by 35
Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
Rocha, J. L. M., de Oliveira, W. C. F., Noronha, N. D. C., dos Santos, N. C. D., Covas, D. T., Picanço‐Castro, V., Swiech, K., & Malmegrim, K. C. R. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10032-7 · Cited by 38
Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
Iglesias, M., Butrón, P., Torre-Villalvazo, I., Torre-Anaya, E. A., Sierra-Madero, J., Rodríguez-Andoney, J. J., Tovar-Palacio, A., Zentella-Dehesa, A., Dominguez-Cherit, G., Rodríguez-Reyna, T., et al. (2021) · Aging and Disease · doi:10.14336/ad.2020.1218 · Cited by 31
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Saleh, M., Kiaei, S. Z. F., & Kavianpour, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02746-x · Cited by 37
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
Harrell, C. R., Jovicic, B. P., Djonov, V., & Volarević, V. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/1939768 · Cited by 35
Self-citation
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Karyana, M., Djaharuddin, I., Rif’ati, L., Arif, M., Choi, M. K., Angginy, N., Yoon, A., Han, J., Josh, F., Arlinda, D., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02812-4 · Cited by 33
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
Zhang, Y., Chen, Y., & Meng, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577442 · Cited by 34
A non-invasive strategy for suppressing asthmatic airway inflammation and remodeling: Inhalation of nebulized hypoxic hUCMSC-derived extracellular vesicles
Xu, X., Wang, Y., Luo, X., Gao, X., Gu, W., Ma, Y., Xu, L., Yu, M., Liu, X., Liu, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150971 · Cited by 33
Lung Multipotent Stem Cells of Mesenchymal Nature: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy
Klein, D. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8190 · Cited by 32
Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19
Roudsari, P. P., Alavi-Moghadam, S., Payab, M., Sayahpour, F. A., Aghayan, H. R., Goodarzi, P., Mohamadi-Jahani, F., Larijani, B. A., & Arjmand, B. (2020) · Cell and Tissue Banking · doi:10.1007/s10561-020-09842-3 · Cited by 32
Lung-Resident Mesenchymal Stem Cell Fates within Lung Cancer
Sentek, H., & Klein, D. (2021) · Cancers · doi:10.3390/cancers13184637 · Cited by 30
Scaling up human mesenchymal stem cell manufacturing using bioreactors for clinical uses
Gazdic, M., Stojković, M., Bojić, S., Jovicic, N. U., Kovačević, M. M., Ivosevic, Z., Juskovic, A., Kovačević, V., & Ljujić, B. (2023) · Current Research in Translational Medicine · doi:10.1016/j.retram.2023.103393 · Cited by 31
Self-citation
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
Chouw, A., Milanda, T., Sartika, C. R., Kirana, M. N., Halim, D., & Faried, A. (2021) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00202-5 · Cited by 26
Umbilical Cord Mesenchymal Stem/Stromal Cells Potential to Treat Organ Disorders; An Emerging Strategy
Ahani-Nahayati, M., Niazi, V., Moradi, A., Pourjabbar, B., Roozafzoon, R., Keshel, S. H., & Baradaran-Rafii, A. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210907164046 · Cited by 27
Molecular Mechanisms Responsible for the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Lung Fibrosis
Harrell, C. R., Djonov, V., Volarevic, A., Arsenijević, A., & Volarević, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084378 · Cited by 29
Self-citation
Complete Blood Count-Derived Inflammatory Markers Changes in Dogs with Chronic Inflammatory Enteropathy Treated with Adipose-Derived Mesenchymal Stem Cells
Cristóbal, J. I., Duque, F. J., Usón-Casaús, J. M., Chacón, R. B., López, E., & Pérez-Merino, E. M. (2022) · Animals · doi:10.3390/ani12202798 · Cited by 26
Cell therapy strategies for COVID-19: Current approaches and potential applications
Zaki, M. M., Lesha, E., Said, K., Kiaee, K., Robinson‐McCarthy, L. R., George, H., Hanna, A., Appleton, E., Liu, S., Ng, A. H. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5995 · Cited by 25
Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties
Joo, H., Oh, M., Kang, J. Y., Park, H. S., Chae, D., Kim, J., Lee, J., Yoo, H. M., Choi, U., Kim, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9020209 · Cited by 25
Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation
Flaifel, A., Kwok, B., Ko, J. P., Chang, S. H., Smith, D. E., Zhou, F., Chiriboga, L. A., Zeck, B., Theise, N. D., Rudym, D., et al. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab208 · Cited by 22
Umbilical cord: an allogenic tissue for potential treatment of COVID-19
Rodriguez, H. C., Gupta, M., Cavazos-Escobar, E., El‐Amin, S. F., & Gupta, A. (2020) · Human Cell · doi:10.1007/s13577-020-00444-5 · Cited by 22
Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis
Kassem, D. H., & Kamal, M. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.587866 · Cited by 22
Applications and therapeutic mechanisms of action of mesenchymal stem cells in radiation-induced lung injury
Niu, S., & Zhang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02279-9 · Cited by 20
Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
Harrell, C. R., Jovicic, B. P., Djonov, V., & Volarević, V. (2021) · Pathogens · doi:10.3390/pathogens10040409 · Cited by 21
Self-citation
Safety study of allogeneic mesenchymal stem cell therapy in animal model
Chan, A. M. L., Ng, M. H., Yunus, M. H. M., Idrus, R. B. H., Law, J. X., Yazid, M. D., Chin, K., Shamsuddin, S. A., Yusof, M. R. M., Razali, R. A., et al. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.01.008 · Cited by 22
Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
Chen, Y., Liu, X., & Tong, Z. (2022) · Cells · doi:10.3390/cells12010006 · Cited by 21
Study of Mesenchymal Stem Cell-Mediated Mitochondrial Transfer in In Vitro Models of Oxidant-Mediated Airway Epithelial and Smooth Muscle Cell Injury
Michaeloudes, C., Li, X., Mak, J., & Bhavsar, P. K. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1225-5_7 · Cited by 20
Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
Liu, C., Xiao, K., & Xie, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.951764 · Cited by 20
The Centrality of Obesity in the Course of Severe COVID-19
Liu, D., Zhang, T., Wang, Y., & Xia, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.620566 · Cited by 22
Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
Li, Z., Hezam, K., Mo, R., Wang, C., & Liu, Y. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210907115126 · Cited by 19
Protective effect of oral stem cells extracellular vesicles on cardiomyocytes in hypoxia-reperfusion
Rocca, Y. D., Diomede, F., Konstantinidou, F., Trubiani, O., Rajan, T. S., Pierdomenico, S. D., Gatta, V., Stuppia, L., Marconi, G. D., & Pizzicannella, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1260019 · Cited by 19
The immunomodulatory effects of mesenchymal stem cells on long term pulmonary complications in an animal model exposed to a sulfur mustard analog
Sadeghi, S., Mosaffa, N., Hashemi, S. M., Naghizadeh, M. M., & Ghazanfari, T. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105879 · Cited by 18
Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases
Arrè, V., Mastrogiacomo, R., Balestra, F., Serino, G., Viti, F., Rizzi, F. R., Curri, M. L., Giannelli, G., Depalo, N., & Scavo, M. P. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040567 · Cited by 17
Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic
Yuan, D. (2024) · American Journal of Stem Cells · doi:10.62347/jawm2040 · Cited by 17
Migrasomes derived from human umbilical cord mesenchymal stem cells: a new therapeutic agent for ovalbumin-induced asthma in mice
Gu, W., Zheng, T., Li, W., Luo, X., Xu, X., Wang, Y., Mao, C., Ma, Y., & Dong, L. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04145-4 · Cited by 17
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system
Williams, A., Branscome, H., Khatkar, P., Mensah, G. A., Sharif, S. A., Pinto, D. O., DeMarino, C., & Kashanchi, F. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00998-6 · Cited by 16
COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs)
Wadan, A.-H. S., & Abdellatif, M. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146835 · Cited by 19
MiR-148a-3p within HucMSC-Derived Extracellular Vesicles Suppresses Hsp90b1 to Prevent Fibroblast Collagen Synthesis and Secretion in Silica-Induced Pulmonary Fibrosis
Jiang, Q., Zhao, J., Jia, Q., Wang, H., Xue, W., Ning, F., Wang, J., Wang, Y., Zhu, Z., & Tian, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914477 · Cited by 16
Effect of intrabronchial administration of autologous adipose-derived mesenchymal stem cells on severe equine asthma
Adamič, N., Mihevc, S. P., Blagus, R., Kramarič, P., Krapež, U., Majdič, G., Viel, L., Hoffman, A. M., Bienzle, D., & Vengušt, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02704-7 · Cited by 16
Mesenchymal Stem Cell-Secreted TGF-β1 Restores Treg/Th17 Skewing Induced by Lipopolysaccharide and Hypoxia Challenge via miR-155 Suppression
Xue, M., Zhang, X., Chen, J., Liu, F., Xu, J., Xie, J., Yang, Y., Yu, W., & Qiu, H. (2022) · Stem Cells International · doi:10.1155/2022/5522828 · Cited by 16
Artificial stem cells mediated inflammation-tropic delivery of antiviral drugs for pneumonia treatment
Qin, A., Chen, S., Li, S., Li, Q., Huang, X., Xia, L., Lin, Y., Shen, A., Xiang, A. P., & Zhang, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01547-x · Cited by 16
Near-infrared-persistent luminescence/bioluminescence imaging tracking of transplanted mesenchymal stem cells in pulmonary fibrosis
Xia, Y., Bao, H., Huang, J., Li, X., Yu, C., Zhang, Z., & Wang, H. (2020) · Biomaterials Science · doi:10.1039/d0bm00063a · Cited by 16
Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021
Yang, Y., Chen, Y., Liu, Y., Ning, Z.-D., Zhang, Z., Zhang, Y., Xu, K., & Zhang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1136761 · Cited by 15
The effects of BMMSC treatment on lung tissue degeneration in elderly macaques
Yang, Y.-K., Li, Y., Wang, Y., Ruan, G., Tian, C., Wang, Q., He, H., Zhu, G., Dong, F., Wang, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02201-3 · Cited by 15
Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p
Meng, S., Chen, H., Deng, C., & Meng, Z. (2023) · Neurotoxicity Research · doi:10.1007/s12640-022-00626-z · Cited by 16
The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19
Zani‐Ruttenstock, E., Antounians, L., Khalaj, K., Figueira, R. L., & Zani, A. (2021) · European Journal of Pediatric Surgery · doi:10.1055/s-0041-1731294 · Cited by 15
Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19
Lu, K., Geng, S.-T., Tang, S.-K., Yang, H., Xiong, W., Xu, F., Yuan, Q., Xiao, X., Huang, R., Liang, H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02743-0 · Cited by 14
Medical progress: Stem cells as a new therapeutic strategy for COVID-19
Musiał, C., & Górska‐Ponikowska, M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102239 · Cited by 14
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches
Zavvar, M., Yahyapoor, A., Baghdadi, H., Zargaran, S., Assadiasl, S., Abdolmohammadi, K., Abooei, A. H., Sattarian, M. R., JalaliFarahani, M., Zarei, N., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108655 · Cited by 15
Potential of Mesenchymal Stem Cell-Based Therapies for Pulmonary Fibrosis
Guo, Z., Zhang, Y., & Yan, F. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0327 · Cited by 13
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
Remuzzi, G., Schiaffino, S., Santoro, M. G., FitzGerald, G. A., Melino, G., & Patrono, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.987816 · Cited by 16
Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19
Ghiasi, M., Zarandi, P. K., Dayani, A., Salimi, A., & Shokri, E. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.03.015 · Cited by 13
Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19
Cheng, X., Jiang, M., Long, L., & Meng, J. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4999 · Cited by 13
pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury
Chen, M.-C., Lai, K. S.-L., Chien, K.-L., Teng, S.-T., Lin, Y.-R., Chao, W., Lee, M.-J., Wei, P., Huang, Y., Kuo, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.871828 · Cited by 12
Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton’s Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33
Gasanov, V. A. O., Kashirskikh, D. A., Khotina, V. A., Kuzmina, D. M., Nikitochkina, S. Y., Mukhina, I. V., Vorotelyak, E. A., & Vasiliev, A. V. (2025) · Cells · doi:10.3390/cells14050341 · Cited by 12
Asthma Immunotherapy and Treatment Approaches with Mesenchymal Stem Cells
Akkoç, T., & Genç, D. (2020) · Immunotherapy · doi:10.2217/imt-2019-0194 · Cited by 12
The Role of MicroRNAs in Mesenchymal Stem Cell–Based Modulation of Pulmonary Fibrosis
Harrell, C. R., Volarević, A., Djonov, V., Arsenijević, A., & Volarević, V. (2024) · Cell Transplantation · doi:10.1177/09636897241281026 · Cited by 11
Self-citation
Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?
Shahani, P., & Datta, I. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.04.004 · Cited by 12
Small Extracellular Vesicles Containing miR-34c Derived from Bone Marrow Mesenchymal Stem Cells Regulates Epithelial Sodium Channel via Targeting MARCKS
Hua, Y., Han, A., Yu, T., Hou, Y., Ding, Y. P., & Nie, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095196 · Cited by 11
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
Chaudhary, J. K., Saini, D., Chaudhary, P. K., Maurya, A., Verma, G. K., Gupta, A. K., Roshan, R., Vats, T. K., Garg, N., Yadav, D., et al. (2022) · Cells · doi:10.3390/cells11142175 · Cited by 11
Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis
Zhang, Z., Shao, S., Liu, X., & Tong, Z. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28702 · Cited by 11
Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities
Rajabi, H., Mortazavi, D., Konyalılar, N., Aksoy, G. T., Erkan, S., Korkunc, S. K., Kayalar, Ö., Bayram, H., & Rahbarghazi‬, R. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00982-5 · Cited by 12

Authors: Harrell, C. R., Sadikot, R., Pascual, J., Fellabaum, C., Jankovic, M. G., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V.
Affiliations: Regenerative Processing Plant, LLC, 34176 UD Highway 19 N Palm Harbor, Palm Harbor, Florida, USA
Emory University (US)
Department of Genetics, Faculty of Medical Sciences, University of Kragujevac, Serbia
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozar Markovic Street, Kragujevac, Serbia
University of Bern (CH)
West Pasco Pulmonary Associates, 7545 Medical Dr, Hudson, Florida, USA
Institute of Anatomy, University of Bern, 2 Baltzerstrasse, Switzerland
ORCID: Harrell, C. Randall
Sadikot, Ruxana
Fellabaum, Crissy
Jovicic, Nemanja
Djonov, Valentin
Volarevic, Vladislav
Venue: Stem Cells International
Publisher: Wiley
Published: 2019-05-02
Volume: 2019
Pages: 1-14
ISSN: 1687-966X (ISSN-L)
1687-9678
DOI: 10.1155/2019/4236973
PMC: PMC6525794
OpenAlex: W2943233832
Cited by: 193
References: 126
Citations by year: 2026: 3 · 2025: 14 · 2024: 18 · 2023: 22 · 2022: 37 · 2021: 58 · 2020: 34 · 2019: 7
FWCI: 4.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: Stem Cells International (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
BORIS (University Library Bern) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Open Access CRIS of the University of Bern
Funders: University of Kragujevac (MP01/18, ON175103, ON175069, 16C197)
Serbian Ministry of Science (MP01/18, ON175103, ON175069, 16C197)
Novartis Foundation (MP01/18, ON175103, ON175069, 16C197)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords: mesenchymal stem cells, cell therapy, inflammatory lung disease, pulmonary fibrosis, acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, immunomodulation, lung injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks